{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:09:59Z","timestamp":1789157399234,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajic.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:21:03Z","timestamp":1778084463000},"page":"1066-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preparing for the next pandemic: Efficacy of 2 commercial glycol vapor and aerosol products against aerosolized surrogate viruses and microbes on surfaces"],"prefix":"10.1016","volume":"54","author":[{"given":"Jennifer L.","family":"Cadnum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1041-1631","authenticated-orcid":false,"given":"Maria M.","family":"Torres-Teran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3262-5282","authenticated-orcid":false,"given":"Samir","family":"Memic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3682-6252","authenticated-orcid":false,"given":"Amelia L.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Kaple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-4498","authenticated-orcid":false,"given":"Curtis J.","family":"Donskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1111\/risa.70054","article-title":"Managing infectious aerosols to counter engineered pandemics: current re--ations and future research","volume":"45","author":"Lerner","year":"2025","journal-title":"Risk Anal"},{"key":"10.1016\/j.ajic.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/infdis\/jiac394","article-title":"Triethylene glycol can be predeployed as a safe virus-killing indoor air treatment","volume":"226","author":"Goldman","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2026.05.001_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxae071","article-title":"Reviewing the evidence of antimicrobial activity of glycols","volume":"135","author":"Duggan","year":"2024","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.ajic.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ajic.2009.06.007","article-title":"Inactivating influenza viruses on surfaces using hydrogen peroxide or triethylene glycol at low vapor concentrations","volume":"37","author":"Rudnick","year":"2009","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2026.05.001_bib5","article-title":"Effectiveness of triethylene glycol disinfection on airborne MS2 bacteriophage under diverse building operational parameters","volume":"1","author":"Sultan","year":"2024","journal-title":"Indoor Environ"},{"key":"10.1016\/j.ajic.2026.05.001_bib6","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202317932","article-title":"Propylene glycol inactivates respiratory viruses and prevents airborne transmission","volume":"15","author":"Styles","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajic.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/infdis\/77.3.177","article-title":"The effect of triethylene glycol vapor on airborne beta hemolytic Streptococci in hospital wards; the action of glycol vapors at low relative humidities","volume":"77","author":"Hamburger","year":"1945","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2026.05.001_bib8","unstructured":"Lysol Air Sanitizer (Kills 99.9% of Bacteria and Viruses). Accessed February 10, 2026. \u3008https:\/\/www3.epa.gov\/pesticides\/chem_search\/ppls\/000777-00143-20220930.pdf\u3009."},{"key":"10.1016\/j.ajic.2026.05.001_bib9","unstructured":"Arresta. Environmental Protection Agency registration 99121-2. Accessed February 10, 2026. \u3008https:\/\/www3.epa.gov\/pesticides\/chem_search\/ppls\/099121-00002-20230306.pdf\u3009."},{"key":"10.1016\/j.ajic.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/02786826.2023.2262004","article-title":"Impact of test methodology on the efficacy of triethylene glycol (Grignard Pure) against bacteriophage MS2","volume":"57","author":"Ratliff","year":"2023","journal-title":"Aerosol Sci Technol"},{"key":"10.1016\/j.ajic.2026.05.001_bib11","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.est.2c08632","article-title":"Efficacy of Grignard Pure to inactivate airborne phage MS2, a common SARS-CoV-2 surrogate","volume":"57","author":"Desai","year":"2023","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.ajic.2026.05.001_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/aem.01426-24","article-title":"Rapid virucidal activity of an air sanitizer against aerosolized MS2 and Phi6 phage surrogates for non-enveloped and enveloped vertebrate viruses, including SARS-CoV-2","volume":"91","author":"Ijaz","year":"2025","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ajic.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/microorganisms12102072","article-title":"The determination of the rapid and effective activity of an air sanitizer against aerosolized bacteria using a room-sized aerobiology chamber","volume":"12","author":"Zargar","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ajic.2026.05.001_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/aem.02335-25","article-title":"Inactivation of airborne pathogen surrogates by triethylene glycol","volume":"92","author":"Desai","year":"2026","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ajic.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajic.2025.04.008","article-title":"The impact of an air sanitizer spray on the risk of virus transmission by aerosols generated by toilet flushing","volume":"53","author":"Boone","year":"2025","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1093\/cid\/ciac006","article-title":"Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with coronavirus disease 2019","volume":"75","author":"Parhizkar","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2026.05.001_bib17","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2025.10107","article-title":"Efficacy of an upper room ultraviolet-C (UV-C) technology versus far UV-C light technologies in reducing aerosolized bacteriophage MS2","volume":"5","author":"Memic","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.ajic.2026.05.001_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.20411\/pai.v5i1.372","article-title":"Effectiveness of ultraviolet-C light and a high-level disinfection cabinet for decontamination of N95 respirators","volume":"5","author":"Cadnum","year":"2020","journal-title":"Pathog Immun"},{"key":"10.1016\/j.ajic.2026.05.001_bib19","series-title":"Standard Quantitative Disk Carrier Test Method for Determining Bactericidal, Virucidal, Fungicidal, Mycobactericidal, and Sporicidal Activities of Chemicals","author":"ASTM International, Designation E2197","year":"2011"},{"key":"10.1016\/j.ajic.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.20411\/pai.v9i2.711","article-title":"Effect of ceftaroline, ceftazidime\/avibactam, ceftolozane\/tazobactam, and meropenem\/vaborbactam on establishment of colonization by vancomycin-resistant Enterococci and Klebsiella pneumoniae in mice","volume":"9","author":"Hausman","year":"2024","journal-title":"Pathog Immun"},{"key":"10.1016\/j.ajic.2026.05.001_bib21","unstructured":"Environmental Protection Agency. Results for Aerosol Treatment Technology Evaluation with Grignard Pure. 2021. Accessed February 10, 2026. \u3008https:\/\/www.epa.gov\/emergency-response-research\/results-aerosol-treatment-technology-evaluation-grignard-pure\u3009."},{"key":"10.1016\/j.ajic.2026.05.001_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajic.2021.03.004","article-title":"Evaluation of dry hydrogen peroxide in reducing microbial bioburden in a healthcare facility","volume":"49","author":"Sanguinet","year":"2021","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2026.05.001_bib23","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ajic.2024.03.013","volume":"52","author":"Trosch","year":"2024","journal-title":"Am J Infect Control"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655326004736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655326004736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:35:29Z","timestamp":1789155329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655326004736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0196655326004736"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2026.05.001","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparing for the next pandemic: Efficacy of 2 commercial glycol vapor and aerosol products against aerosolized surrogate viruses and microbes on surfaces","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.","name":"copyright","label":"Copyright"}]}}